News & Updates

Diabetes and COVID-19: What have we learned so far?
Diabetes and COVID-19: What have we learned so far?
09 Dec 2022 byKanas Chan

Evidence for excess risk and increased burden of new-onset diabetes among COVID-19 survivors is robust, and most antihyperglycaemic drugs can be used safely during acute COVID-19, with some drugs potentially offering protection against serious complications, according to data presented at 5th EDM HK.

Diabetes and COVID-19: What have we learned so far?
09 Dec 2022
Maximum home BP predicts cardiovascular outcomes in T2D patients
Maximum home BP predicts cardiovascular outcomes in T2D patients
02 Dec 2022

In patients with type 2 diabetes (T2D), maximum home blood pressure (BP) may be used as a potential marker of subsequent cardiovascular events, suggests a retrospective cohort study.

Maximum home BP predicts cardiovascular outcomes in T2D patients
02 Dec 2022
Pituitary TF–based classification improves diagnostic accuracy and prognostication of nonfunctioning PitNETs
Pituitary TF–based classification improves diagnostic accuracy and prognostication of nonfunctioning PitNETs
30 Nov 2022
Low-carb vegan diet reduces weight, greenhouse gas emissions
Low-carb vegan diet reduces weight, greenhouse gas emissions
23 Nov 2022